Summary

• Study director: William Jagust, MD and Gil Rabinovici, MD
• Sponsors: National Institutes of Health (NIH) and the Alzheimer’s Association
• Recruiting?: Yes
• Official study title: Amyloid PET in AD, FTLD & PPA: Diagnosis, Functional & Structural Correlations
• Conditions studied: Behavioral variant frontotemporal dementia (bvFTD), semantic dementia (SD), progressive nonfluent aphasia (PNFA), Alzheimer's disease (AD), logopenic progressive aphasia (LPA), primary progressive aphasia (PPA), posterior cortical atrophy (PCA) and corticobasal degeneration (CBD)
• Purpose: The purpose of this study is to determine if amyloid PET imaging with Pittsburgh Compound-B (PIB) can improve diagnostic accuracy in discriminating between AD and FTD.

article_image_comp: